|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/107 | |
| A61K 9/48 | |||
| A61K 31/568 | |||
| A61K 47/12 | |||
| A61K 47/14 | |||
| A61K 47/44 |
| (11) | Number of the document | 2558073 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10714521.1 |
| Date of filing the European patent application | 2010-04-12 | |
| (97) | Date of publication of the European application | 2013-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2014-09-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/030788 |
| Date | 2010-04-12 |
| (87) | Number | WO 2011/129812 |
| Date | 2011-10-20 |
| (72) |
DUDLEY, Robert, E., US
CONSTANTINIDES, Panayiotis, P., US
|
| (73) |
Clarus Therapeutics, Inc.,
555 Skokie Boulevard, Suite 340, Northbrook, IL 60062,
US
|
| (54) | ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME |
| ORAL TESTOSTERONE ESTER FORMULATIONS AND METHODS OF TREATING TESTOSTERONE DEFICIENCY COMPRISING SAME |